Matt Franklin
@drmattfranklin
Senior Health Economist. School of Medicine and Population Health lead for Consultancy and Partnerships, University of Sheffield
ID: 1131509524291031042
23-05-2019 10:37:47
203 Tweet
283 Followers
196 Following
This is cool: my colleague John Holmes is on the latest BBC More or Less talking about those OECD figures that showed British women as the biggest binge drinkers in the world. bbc.co.uk/sounds/play/w3โฆ
During this webinar, Peter Tennant has moved to Bluesky will talk about causal inference and DAGs, alongside the biggest question of them all: why should I care? ๐ค Expect to go through the 7 stages of causal grief, in particular shock, denial, before (eventual) acceptance. I'm looking forward to it!
โฐ Thereโs still time to sign up! Tomorrow, โAn introduction to causal inference and directed acyclic graphsโ will be hosted by Peter Tennant has moved to Bluesky at 13:00 CET. Make sure you donโt miss out on this webinar ๐ bit.ly/3uCsXtN
New research paper evaluating the impact of adding health and well-being support to address the wider determinants of mental health to an existing NHS mental health service (IAPT) bmjopen.bmj.com/content/14/1/eโฆ Funded by NIHR SPHR Matt Franklin @frankdevocht Esther Curtin
First 15 minutes of the web video is my simply explained overview of real-world data (RWD), what public benefits could be achieved, and the importance of public trust in secondary RWD uses. Thanks to Open Research TUoS for the invite! Unlocking Data project NIHR Yorkshire & Humber ARC National Institute for Health and Care Research
The understanding, purpose, and need of within-trial economic evaluations has somewhat been lost. Rachael Maree Hunter and I have provided an updated perspective for justifying within-trial economic evaluations alongside or instead of decision-analytic models doi.org/10.1007/s41669โฆ
Need to map from PHQ-9/GAD-7 to EQ-5D-3L for economic evaluation (who doesn't?)? Clara's latest paper has you covered: rdcu.be/dF63D Matt Franklin NIHR Yorkshire & Humber ARC The Centre for Health Economics SCHARR
FUNDED PHD OPPORTUNITY: Estimation and subsequent use of health state utilities in cost-effectiveness models. Come study with in experts in economic modelling and utility values SCHARR The University of Sheffield. Part funded by OPEN Health. Advert here: findaphd.com/phds/project/eโฆ
5+ years ago, Joanna Thorn and I wrote about using self-reported and routinely collected data to inform economic evaluations. With the growing interest in real-world data, I re-read our paper...I think a lot of what we said then still holds true now! See here: doi.org/10.1186/s12874โฆ
With 11K+ accesses over the last three months, it would appear people are interested in our review and results! In collaboration with AstraZeneca and other colleagues at SCHARR including Daniel Pollard
New Global Health Economics Centre + Anirban Basu + Amanda I Adler + Karla DO paper on HEC Editors! We used target trial emulation with local #IVs to examine treatment effect heterogeneity across subpopulations eligible and ineligible for a published RCT onlinelibrary.wiley.com/doi/10.1002/heโฆ
We're recruiting a 15 month post-doc research associate position to help us evaluate the health consequences among the elderly of the disability benefit reform in England from DLA to PIP. Economics at York Deadline 13th November. jobs.york.ac.uk/vacancy/researโฆ
New paper published in Statistical Methods in Medical Research with Yirui Qian, Laura Flight and Stephen Walters Comparison of statistical methods for the analysis of patient-reported outcomes in randomised controlled trials: A simulation study journals.sagepub.com/doi/10.1177/09โฆ
Yesterday we had our first hybrid meeting for our new target trials LEAP! Here's a few members from our (14 member!) group who came along in person ๐ To read more about this new project, click here๐ โฆs-mental-health.sites.sheffield.ac.uk Rachel Kimberley Temple Matt Franklin The McPin Foundation
